
Slovenia allows controlled medical use of cannabis, while recreational...

Cannabidiol (CBD) from Cannabis sativa L. offers significant therapeutic...
Stay informed with the latest updates from Farmakem — from new GMP/GDP certifications and product launches to regulatory insights and developments in the pharmaceutical and cannabinoid API sector.
Share the details of your request and our team will respond promptly.
info@farmakem.si
+386 262 007 91
Mon–Fri: 8:00 a.m. – 4:00 p.m.
info@farmakem.si
+386 262 007 91
Mon–Fri: 8 a.m. – 4 p.m.
info@farmakem.si
+386 262 007 91
Mon–Fri: 8 a.m. – 4 p.m.